Cargando…
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
BACKGROUND: Bronchopulmonary dysplasia (BPD) is a major cause of mortality and long-term respiratory and neurological morbidity in very preterm infants. While survival rates of very preterm infants have increased over the past two decades there has been no decrease in the rate of BPD in surviving in...
Autores principales: | Collins, Carmel T., Gibson, Robert A., Makrides, Maria, McPhee, Andrew J., Sullivan, Thomas R., Davis, Peter G., Thio, Marta, Simmer, Karen, Rajadurai, Victor S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896378/ https://www.ncbi.nlm.nih.gov/pubmed/27250120 http://dx.doi.org/10.1186/s12887-016-0611-0 |
Ejemplares similares
-
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023) -
Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary Dysplasia
por: Ryan, Feargal J., et al.
Publicado: (2019) -
Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021) -
Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis
por: Marc, Isabelle, et al.
Publicado: (2023) -
Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
por: Collins, Carmel T, et al.
Publicado: (2015)